Moneycontrol PRO

Cadila: More a COVID hedge in the near term

Cadila's India presence -- at about 45 per cent of sales -- is similar in size as the US business and provides better cash-flow visibility

August 12, 2021 / 11:55 AM IST
Cadila: More a COVID hedge in the near term

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Cadila Healthcare’s (CMP: Rs 563, Market Cap: Rs 57,713 crore) Q1FY22 result has underlined the return of higher-than-expected pricing erosion risk in the US market. A commentary across the sector is not favourable on this front, which leads us to evaluate how one should position for the stock. Q1 takeaways (image) Cadila posted a 15 per cent sales growth, led by a strong traction in domestic formulations (64 per cent YoY) and emerging markets (17 per cent YoY), partly offset by...

  • PRO Panorama

    Moneycontrol Pro Panorama | The inflation story has a sting in the tail

    Oct 22, 2021 / 04:18 PM IST

    Also in today’s edition of Moneycontrol Pro Panorama: Bitcoin’s risk quotient, the Weekly Tactical, Havells India stays the course, the Herd Immunity Tracker, COP26 has its task cut out, the curse of ‘old economy’ and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | The Maharaja has left the building

    Oct 9, 2021 / 11:27 AM IST

    Privatisation of Air India means a one-time hit to the exchequer in the form of debt, but it’s a small price to pay for the government

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers